| Number (%) or Mean value (range) | |
---|---|---|
Number | 170 (100) | Â |
Age (year) | Â | 65.5 (40 to 78) |
PSA (ng/ml) | Â | 7.4 (2.8 to 25.9) |
Prostate volume (cc) | Â | 40.2 (13.8 to 87.9) |
PSA density (ng/ml/cc) | Â | 0.208 (0.050 to 1.124) |
Biospy core (n) | Â | 13.1 (6 to 24) |
Tumor length (mm) | Â | 2.1 (0.1 to 7.0) |
Biopsy approach | Â | Â |
Transrectal | 137 (80.6) | Â |
Transperineal | 33 (19.4) | Â |
Positive core | Â | Â |
1 | 120 (70.6) | Â |
2 | 50 (29.4) | Â |
Biopsy Gleason score | Â | Â |
5 | 7 (4.1) | Â |
6 | 163 (95.9) | Â |
Clinical T stage(DRE) | Â | Â |
cT1c | 154 (90.6) | Â |
cT2a | 16 (9.4) | Â |
MRI findings | Â | Â |
Negative | 113 (66.5) | Â |
Positive | 57 (33.5) | Â |
Epstein criteria | Â | Â |
Yes | 70 (41.2) | Â |
No | 100 (58.8) | Â |
PRIAS criteria | Â | Â |
Yes | 103 (60.6) | Â |
No | 67 (39.4) | Â |